Evidence map›Paper›PMID 34106301›Full record

ReviewAbdominal radiology (New York)2021

LI-RADS treatment response lexicon: review, refresh and resolve with emerging data.

Roopa Ram, Rony Kampalath, Anuradha S Shenoy-Bhangle, Sandeep Arora, Ania Z Kielar, Mishal Mendiratta-Lala

Abstract readReview
PubMed Publisher
In one paragraph

Review in Abdominal radiology (New York), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Local-Regional Treatment of Hepatocellular Carcinoma: A Primer for Radiologists.Radiographics : a review publication of the Radiological Society of North America, Inc · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 2 countries.

Roopa Ram *University of Arkansas for Medical Sciences, 4301 W. Markham St, Little Rock, Ar, 72205, USA. rram@uams.edu.ORCID http://orcid.org/0000-0002-8536-1221
Rony KampalathRadiological Sciences, University of California, Irvine, 101 The City Drive South, Bldg. 1, Rt. 140, Mail Code: 5005, Orange, CA, 92868, USA.
Anuradha S Shenoy-BhangleDivision of Abdominal Imaging and Interventions, Harvard Medical School, Beth Israel Deaconess Medical Center, Shapiro 4, 330 Brookline Avenue, Boston, MA, 02115, USA.
Sandeep AroraDepartment of Radiology and Biomedical Imaging, Yale University, 333 Cedar Street, New Haven, CT, 06510, USA.
Ania Z KielarDept of Medical Imaging, Toronto General Hospital, University of Toronto, 585 University Ave, Toronto, ON, M5G2N2, Canada.
Mishal Mendiratta-LalaAbdominal and Cross-Sectional Interventional Radiology, University of Michigan, 1500 E Medical Center Dr, UH B2 A209R, Ann Arbor, MI48109, USA.
Beth Israel Deaconess Medical Center · USUniversity of Arkansas for Medical Sciences · USUniversity of California, Irvine · USUniversity of Michigan · USUniversity of Toronto · CAYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The imaging findings after loco regional treatment of hepatocellular carcinoma are variable based on the type of treatment used, the timing interval of imaging after treatment, and the cross-sectional modality used for treatment response assessment. Liver Imaging Reporting and Data System (LI-RADS) Treatment Response Algorithm (TRA) is a relatively new standardized method of evaluating treatment response after loco regional therapy to hepatocellular carcinoma. In this article, we provide an overview of the evolution of the treatment response algorithm, its current applicability and its outlook for the future. We will review current guidelines and discuss proposed changes to the algorithm as a means to continually improve LI-RADS TRA as an assessment tool post-loco regional treatment of hepatocellular carcinoma.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsCross-Sectional StudiesHumansMagnetic Resonance ImagingTomography, X-Ray ComputedHepatocellular carcinomaRadioembolizationTreatment response

Identifiers

PMID34106301
OpenAlexW3170251448

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.